Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 127
  • Start Date: July 16, 2021
A Multicenter, Single Arm, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 36
  • Start Date: February 11, 2021
A Two-arm, Randomized, Double-blind, Placebocontrolled, Monocentric Study to Evaluate the Safety and Tolerability of ACT-01 Compared to Placebo in Patients With Acute Optic Neuritis
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Device
  • Participants: 42
  • Start Date: February 8, 2021
High Frequency Impulse Therapy for Neuropathic Pain in NMOSD
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 200
  • Start Date: December 17, 2020
RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 350
  • Start Date: October 31, 2020
Study on the Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica and Gene Polymorphism: a Cohort Study
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 150
  • Start Date: October 22, 2020
VISIONARY-MS LTE: A Multi-Center, Open-Label Long-Term Extension Study Assessing the Safety, Efficacy, Tolerability, and Pharmacokinetics of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Biological, Drug
  • Participants: 12
  • Start Date: September 22, 2020
An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment of Relapsed/Refractory Antibody-associated Idiopathic Inflammatory Diseases of the Nervous System
Clinical Trial
  • Status: Recruiting
  • Participants: 60
  • Start Date: September 14, 2020
Evaluation and Follow-up of Optic Neuritis Not Related to Multiple Sclerosis
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 30
  • Start Date: June 15, 2020
IMCY-NMO-000 In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized Neuromyelitis Optica (PHASE 0)
Clinical Trial
  • Status: Recruiting
  • Participants: 200
  • Start Date: May 15, 2020
An Diagnostic Cohort on Applicability and Accuracy of AQP4-Immunoglobulin G Detection Kit in the Diagnosis of Neuromyelitis Optica Spectrum Disorders
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 1000
  • Start Date: May 1, 2020
Epidemiologic and Clinical Characteristics of Optic Neuritis in China
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 2000
  • Start Date: April 20, 2020
Cohort Study Evaluating the Epidemiological Characteristics of Coronavirus Infection (SARS-CoV-2) in Patients With MS or NMO
Showing 1-12 of 50